Achillion Pharmaceuticals, Inc. Reports 2007 Fourth Quarter and Year-End Financial Results

NEW HAVEN, Conn., Feb. 27, 2008 (PRIME NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN), a leader in the discovery and development of small molecule drugs to combat the most challenging infectious diseases, today reported financial results for the quarter and year ended December 31, 2007.

Back to news